Key regions: United Kingdom, China, Europe, India, France
The Other Vaccines market in Poland has been steadily developing in recent years.
Customer preferences: Polish customers have shown a growing interest in preventative healthcare measures, including vaccinations. This has led to an increase in demand for Other Vaccines, which are used to prevent diseases other than the flu and are not included in the mandatory vaccination schedule.
Trends in the market: The Other Vaccines market in Poland has been growing due to a number of factors. Firstly, an increasing number of people are becoming aware of the importance of preventative healthcare measures. Secondly, there has been a rise in the number of private medical facilities offering vaccines, which has made them more accessible to the general public. Finally, the COVID-19 pandemic has raised awareness about the importance of vaccinations and has led to an increase in demand for all types of vaccines.
Local special circumstances: The Other Vaccines market in Poland is also influenced by local circumstances. For example, the country has a high incidence of tick-borne diseases, such as Lyme disease, which has led to an increase in demand for vaccines against these diseases. Additionally, there is a growing trend of parents choosing to vaccinate their children against diseases that are not included in the mandatory vaccination schedule, such as chickenpox.
Underlying macroeconomic factors: The Polish economy has been growing steadily in recent years, which has led to an increase in disposable income for many households. This has made it easier for people to afford preventative healthcare measures, such as vaccinations. Additionally, the government has been investing in healthcare infrastructure, which has led to an increase in the number of medical facilities offering vaccines.In conclusion, the Other Vaccines market in Poland is developing due to a combination of factors, including increasing awareness of preventative healthcare measures, a rise in the number of private medical facilities offering vaccines, and the impact of the COVID-19 pandemic. Local circumstances, such as the high incidence of tick-borne diseases, have also contributed to the growth of the market. The underlying macroeconomic factors, including the growth of the Polish economy and government investment in healthcare infrastructure, have also played a role in the development of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
